Cargando…

FRMD6 inhibits human glioblastoma growth and progression by negatively regulating activity of receptor tyrosine kinases

FRMD6 is an Ezrin/Radixin/Moesin (ERM) family protein and a human homologue of Drosophila expanded (ex). Ex functions in parallel of Drosophila merlin at upstream of the Hippo signaling pathway that controls proliferation, apoptosis, tissue regeneration, and tumorigenesis. Even though the core kinas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yin, Wang, Kaiqiang, Yu, Qin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342536/ https://www.ncbi.nlm.nih.gov/pubmed/27661120 http://dx.doi.org/10.18632/oncotarget.12148

Ejemplares similares

Role of Receptor Tyrosine Kinases and Their Ligands in Glioblastoma
por: Carrasco-García, Estefanía, et al.
Publicado: (2014)

The Alternative Splice Variant of Protein Tyrosine Kinase 6 Negatively Regulates Growth and Enhances PTK6-Mediated Inhibition of β-Catenin
por: Brauer, Patrick M., et al.
Publicado: (2011)

Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme
por: Tilak, Manali, et al.
Publicado: (2021)

Negative regulation of ErbB family receptor tyrosine kinases
por: Sweeney, C, et al.
Publicado: (2004)

Expression and regulation of FRMD6 in mouse DRG neurons and spinal cord after nerve injury
por: Lyu, Chuang, et al.
Publicado: (2020)

Receptor tyrosine kinases as druggable targets in glioblastoma: Do signaling pathways matter?
por: Qin, Anna, et al.
Publicado: (2021)

The Role of FRMD7 in Idiopathic Infantile Nystagmus
por: Watkins, Rachel J., et al.
Publicado: (2012)

The ADAM17 sheddase complex regulator iTAP/Frmd8 modulates inflammation and tumor growth
por: Badenes, Marina, et al.
Publicado: (2023)

Regulation of the Receptor Tyrosine Kinase AXL in Response to Therapy and Its Role in Therapy Resistance in Glioblastoma
por: Scherschinski, Lea, et al.
Publicado: (2022)

Negative Regulation of Receptor Tyrosine Kinase (RTK) Signaling: A Developing Field
por: Ledda, Fernanda, et al.
Publicado: (2007)

Receptor tyrosine kinase targeting in glioblastoma: performance, limitations and future approaches
por: Alexandru, Oana, et al.
Publicado: (2020)

Receptor tyrosine kinases: role in cancer progression
por: Sangwan, V., et al.
Publicado: (2006)

The Receptor Tyrosine Kinase AXL in Cancer Progression
por: Rankin, Erinn B., et al.
Publicado: (2016)

miR-219-5p Inhibits Receptor Tyrosine Kinase Pathway by Targeting EGFR in Glioblastoma
por: Rao, Soumya Alige Mahabala, et al.
Publicado: (2013)

Inhibiting receptor tyrosine kinase AXL with small molecule inhibitor BMS-777607 reduces glioblastoma growth, migration, and invasion in vitro and in vivo
por: Onken, Julia, et al.
Publicado: (2016)

Willin/FRMD6: A Multi-Functional Neuronal Protein Associated with Alzheimer’s Disease
por: Chen, Doris, et al.
Publicado: (2021)

Willin/FRMD6 Mediates Mitochondrial Dysfunction Relevant to Neuronal Aβ Toxicity
por: Chen, Doris, et al.
Publicado: (2022)

Abnormal retinal development associated with FRMD7 mutations
por: Thomas, Mervyn G., et al.
Publicado: (2014)

Correlations of FRMD7 gene mutations with ocular oscillations
por: Huang, Lijuan, et al.
Publicado: (2022)

Receptor-Tyrosine Kinase Inhibitor Ponatinib Inhibits Meningioma Growth In Vitro and In Vivo
por: Yu, Tao, et al.
Publicado: (2021)

The Receptor Tyrosine Kinase FGFR4 Negatively Regulates NF-kappaB Signaling
por: Drafahl, Kristine A., et al.
Publicado: (2010)

Co-survival of the fittest few: mosaic amplification of receptor tyrosine kinases in glioblastoma
por: Chen, Feng, et al.
Publicado: (2012)

Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma
por: Bolcaen, Julie, et al.
Publicado: (2021)

Willin/FRMD6 Influences Mechanical Phenotype and Neuronal Differentiation in Mammalian Cells by Regulating ERK1/2 Activity
por: Kronenberg, Nils M., et al.
Publicado: (2020)

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Up-regulates Interleukin-6 in Cancer Cells and Induces Subsequent Development of Interstitial Pneumonia
por: Ishiguro, Yukari, et al.
Publicado: (2013)

Identification of a novel FRMD7 splice variant and functional analysis of two FRMD7 transcripts during human NT2 cell differentiation
por: Li, Yingzhi, et al.
Publicado: (2011)

Protein tyrosine kinase 6 regulates activation of SRC kinase
por: Alwanian, Wanian M., et al.
Publicado: (2022)

FRMD3 inhibits the growth and metastasis of breast cancer through the ubiquitination-mediated degradation of vimentin and subsequent impairment of focal adhesion
por: Shao, Wenjun, et al.
Publicado: (2023)

Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer
por: Tsai, Yuan-Chin, et al.
Publicado: (2018)

Analysis of the Role of FRMD5 in the Biology of Papillary Thyroid Carcinoma
por: Gaweł, Agata M., et al.
Publicado: (2021)

Epidermal growth factor receptor tyrosine kinase inhibitors
por: Ranson, M
Publicado: (2004)

The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells
por: Welsh, James W, et al.
Publicado: (2009)

Analysis of copy number loss of the ErbB4 receptor tyrosine kinase in glioblastoma
por: Jones, DeAnalisa C., et al.
Publicado: (2018)

Should Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Be Continued beyond Progressive Disease?
por: Kim, Young Hak, et al.
Publicado: (2011)

Evaluation of Tyrosine Kinase Inhibitor Combinations for Glioblastoma Therapy
por: Joshi, Avadhut D., et al.
Publicado: (2012)

MBP-11901 Inhibits Tumor Growth of Hepatocellular Carcinoma through Multitargeted Inhibition of Receptor Tyrosine Kinases
por: Park, Hyun Jin, et al.
Publicado: (2022)

Implications of the Receptor Tyrosine Kinase Axl in Gastric Cancer Progression
por: He, Lirui, et al.
Publicado: (2020)

Interactions between Type III receptor tyrosine phosphatases and growth factor receptor tyrosine kinases regulate tracheal tube formation in Drosophila
por: Jeon, Mili, et al.
Publicado: (2012)

High Levels of Receptor Tyrosine Kinases in CCM3-Deficient Cells Increase Their Susceptibility to Tyrosine Kinase Inhibition
por: Sartages, Miriam, et al.
Publicado: (2020)

Negative Regulation of Ros Receptor Tyrosine Kinase Signaling: An Epithelial Function of the Sh2 Domain Protein Tyrosine Phosphatase Shp-1
por: Keilhack, Heike, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_qbu9h7438dn4pb49etqrdqhfik